Genprex (GNPX) Issues Shareholder Update

Go back to Genprex (GNPX) Issues Shareholder Update

Genprex Issues Shareholder Letter and Provides Corporate Update

February 1, 2021 1:30 PM EST

Major milestones achieved in advancing gene therapies for lung cancer and diabetes

Company looks toward launching key clinical trials in lung cancer in 2021

AUSTIN, Texas--(BUSINESS WIRE)-- Genprex, Inc. (Genprex or the Company) (NASDAQ:... More